Print Friendly, PDF & Email

NCT/Study#

NCT04947319 /

ONO-4059-09

An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma (PCNSL)

DISEASE GROUP:
Neuro-Oncology
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: